The BCG unresponsive NMIBC market is anticipated to witness a substantial positive shift owing to better uptake of existing drugs, the expected market launch of photodynamic therapy and non-viral gene therapy, and raised awareness. LAS VEGAS, July 3, 2024 /PRNewswire/ — DelveInsight’s…